Objective To investigate the dynamic changes in collagen parameters in mice with nonalcoholic fatty liver disease (NAFLD) by second harmonic generation (SHG) /two-photon excitation fluorescence (TPEF) , to establish the parameters for automatic quantitative evaluation of mice with NAFLD induced by methionine-and choline-deficient diet (MCD) , and to provide an experimental basis for the application of SHG/TPEF in clinical practice. Methods Liver tissue specimens of MCD mice were collected at weeks 0, 4, 8, 12, 16, 20, and 24, and HE staining, Masson staining, and sirius red (SR) staining were performed. Collagen proportionate area (CPA) and hydroxyproline (HYP) were calculated. SHG/TPEF was used to analyze 100 collagen parameters. With time points and fibrosis stage (S0-S4) as criteria, the SVM model was used to analyze the collagen parameters. A receiver operating characteristic (ROC) curve analysis was performed for the collagen parameters, and these parameters were compared with CPA and HYP in terms of the area under the ROC curve (AUC) . Results In the MCD mice, HE and SR staining showed that over the time of modeling, hepatic steatosis was observed in hepatic lobules, with gradual aggravation of fibrosis. A total of 26 parameters were screened out based on their correlation with time point, and 27 parameters were screened out based on their correlation with liver fibrosis stage. The analysis based on the SVM model identified 7 shared parameters (#StrCV, #ShortStrCV, #ThickStrCV, #StrPTAgg, #StrPSAgg, #LongStrPSAgg, and StrLengthPSAgg) . These 7 parameters had anAUC of 0. 857-0. 923 (P < 0. 05) in predicting different stages of liver fibrosis and an AUC of 0. 823-0. 976 (P < 0. 05) in predicting liver fibrosis at different time points. These 7 parameters were compared with CPA and HYP in terms of their value in predicting liver fibrosis, and it was found that the 7 parameters had a similar AUC as CPA and HYP in predicting S0 fibrosis, while the 7 parameters had a significantly higher AUC than CPA and HYP in predicting S1-S4 fibrosis. The 7 parameters had a similar AUC as CPA and HYP at week 0 of modeling, while at week 4 of modeling, the 7 parameters had a significantly higher AUC than CPA and HYP. Conclusion Seven parameters associated with fibrosis stage and time point can accurately reflect the changes in liver fibrosis in different stages and at different time points in a model of MCD-induced NAFLD, and therefore, they can be used for specific and accurate monitoring of liver fibrosis in a quantitative manner in this model.
[1] YOUNOSSI Z, ANSTEE QM, MARIETTI M, et al. Global burden of NAFLD and NASH:Trends, predictions, risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol, 2018, 15 (1) :11-20.
|
[2] LI J. Epidemiology characteristics of nonalcoholic fatty liver disease in Asia[J]. J Clin Hepatol, 2018, 34 (12) :2515-2519. (in Chinese) 李婕.亚洲地区非酒精性脂肪性肝病的流行病学特点[J].临床肝胆病杂志, 2018, 34 (12) :2515-2519.
|
[3] LI XH, WEI L. Heterogeneity and homogeneity of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2018, 34 (12) :2491-2494. (in Chinese) 李晓鹤, 魏来.非酒精性脂肪性肝病的同质性和异质性[J].临床肝胆病杂志, 2018, 34 (12) :2491-2494.
|
[4] ADAMS LA, ANSTEE QM, TILG H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut, 2017, 66 (6) :1138-1153.
|
[5] DULAI PS, SINGH S, PATEL J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis[J]. Hepatology, 2017, 65 (5) :1557-1565.
|
[6] ANGULO P, KLEINER DE, DAM-LARSEN S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2015, 149 (2) :389-397.
|
[7] EKSTEDT M, HAGSTRM H, NASR P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up[J]. Hepatology, 2015, 61 (5) :1547-1554.
|
[8] CHEN YZ, CHEN CL, TIAN X, et al. Research advances in animal models based on the pathogenesis and treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2017, 33 (12) :2457-2461. (in Chinese) 陈艳珍, 陈成良, 田兴, 等.基于非酒精性脂肪性肝病机制及治疗的动物模型研究进展[J].临床肝胆病杂志, 2017, 33 (12) :2457-2461.
|
[9] SUN W, CHANG S, TAI DC, et al. Nonlinear optical microscopy:Use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies[J]. J Biomed Opt, 2008, 13 (6) :064010.
|
[10] XU S, WANG Y, TAI DC, et al. qFibrosis:A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J]. J Hepatol, 2014, 61 (2) :260-269.
|
[11] WANG TH, CHEN TC, TENG X, et al. Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy[J]. Sci Rep, 2015, 5:12962.
|
[12] SUN Y, ZHOU J, WU X, et al. Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable”patients on anti-HBV therapy[J]. Sci Rep, 2018, 8 (1) :2989.
|
[13] WANG Y, VINCENT R, YANG J, et al. Dual-photon microscopy-based quantitation of fibrosis-related parameters (qFP) to model disease progression in steatohepatitis[J]. Hepatology, 2017, 65 (6) :1891-1903.
|
[14] LIU F, ZHAO JM, RAO HY, et al. Second harmonic generation reveals subtle fibrosis differences in adult and pediatric nonalcoholic fatty liver disease[J]. Am J Clin Pathol, 2017, 148 (6) :502-512.
|
[15] LIU F, CHEN L, RAO HY, et al. Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation/two-photon excited fluorescence microscopy[J]. Lab Invest, 2017, 97 (1) :84-92.
|
[16] ZHENG YJ, WANG Y. Histological assessment of reversal of liver fibrosis and cirrhosis[J]. J Clin Hepatol, 2019, 35 (4) :709-713. (in Chinese) 郑永见, 汪艳.肝纤维化和肝硬化逆转的组织学评价[J].临床肝胆病杂志, 2019, 35 (4) :709-713.
|
[17] KLEINER DE, BRUNT EM, VAN NATTA M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41 (6) :1313-1321.
|
[18] JULURI R, VUPPALANCHI R, OLSON J, et al. Generalizability of the nonalcoholic steatohepatitis clinical research network histologic scoring system for nonalcoholic fatty liver disease[J]. J Clin Gastroenterol, 2011, 45 (1) :55-58.
|